This study investigates pancreatic cancer using a new imaging test called FAPI PET. The purpose of this study is to identify the disease earlier than current methods allow.
This study evaluates the effectiveness of FAPI PET in detecting cancer progression and relapse. It focuses on how well this imaging can find cancer at different stages and after surgery.
- Who can participate: Adults over 18 with a recent diagnosis of non-metastatic pancreatic cancer who are part of the HoMING cohort can participate. Participants must have social security and provide informed consent.
- Study details: Participants will undergo FAPI PET scans during their treatment process.